During the interview, Mr. Joyce discusses recent data-driven milestones that reinforce the potential for Sigyn Therapy™ to overcome the limitations of previous strategies to treat sepsis and other life-threatening inflammatory conditions. […]
TORONTO – January 19, 2021 − CANAQUEST MEDICAL CORP (OTC Markets: “CANQF”) (the “Company” or “CanaQuest”), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), is pleased to release a recent interview with […]
is pleased to announce it has completed an extensive data compilation program resulting in the identification of highly elevated gold, copper and silver occurrences spread across the 8,136 hectare Lucky Mike Silver Lode Project […]
CEO Jim Joyce discusses Sigyn’s recent news over the last couple months which includes a pilot study to address inflammatory CytoVesicles. […]
Mr. Kenney is a long-established influencer and identifier of trends whose ability to reach broad audiences and access some of the top names in the entertainment industry […]
Dr. Alen Davidoff provided an update on his previous interview from August 2020. Xortx just announced a recent grant on their European patent as well as other activity in the market. The company is hoping to start on their phase III trial on their autosomal dominant polycystic kidney disease program in the next quarter as well as up-list to a higher-tiered US exchange. […]
The Company has generated approximately 134 tons of pressed filter cake PGM concentrate and delivered approximately 32.18 tons during 2020 […]
Entheon has participated in a Series A Preferred Stock Financing, investing $200,000 USD for a 5% stake in Heading Health. […]
Interview with Joseph LaStella, President/Chairman and Kristy Hunt, Operations Manager […]
● Patent supporting Autosomal Dominant Polycystic
Kidney Disease Granted – XRx-008 Program ● […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com